Top

Published in:

01-07-2016 | Original Article

Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population

Authors: Sunaina Thapa, Freda Lalrohlui, Souvik Ghatak, John Zohmingthanga, Doris Lallawmzuali, Jeremy L. Pautu, Nachimuthu Senthil Kumar

Published in: Breast Cancer | Issue 4/2016

Abstract

Background

Mizoram has the highest incidence of cancer in India. Among women, breast cancer is most prevalent and the state occupies fifth position globally. The reason for high rate of cancer in this region is still not known but it may be related to ethnic/racial variations or lifestyle factors.

Methods

The present study aims to identify the candidate mitochondrial DNA (mtDNA) biomarkers—ND1and ATPase for early breast cancer diagnosis in Mizo population. Genomic DNA was extracted from blood samples of 30 unrelated breast cancer and ten healthy women. The mtNDI and mtATP coding regions were amplified by step-down PCR and were subjected to restriction enzyme digestion and direct sequencing by Sanger method. Subsequently, the results of the DNA sequence analysis were compared with that of the revised Cambridge Reference Sequence (rCRS) using Mutation Surveyor and MITOMAP.

Results

Most of the mutations were reported and new mutations that are not reported in relationship with breast cancer were also found. The mutations are mostly base substitutions. The effect of non-synonymous substitutions on the amino acid sequence was determined using the PolyPhen-2 software. Statistical analysis was performed for both cases and controls. Odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated from logistic regression. High intake of animal fat and age at menarche was found to be associated with a higher risk of breast cancer in Mizo population.

Conclusion

Our results also showed that ATPase6 as compared to ATPase8 gene is far more predisposed to variations in Mizo population with breast cancer and this finding may play an important role in breast cancer prognosis.

Available only for authorised users

Phukan RK, Zomawia E, Hazarika NC, Baruah D, Mahanta J. High prevalence of stomach cancer among the people of Mizoram, India. Curr Sci. 2004;87:3.

Perou CM, Sorlie T, Eisen MB, Van De Rijn M, Jeffrey SS. Molecular portraits of human breast tumours. Nature. 2000;406:747–52.CrossRefPubMed

Man Yu, Yurong S, Fei Z, Yunli Z, Yi Y, Xiyin W, Lin Z, Ruifang N. Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci. 2008;15(4):535–43.CrossRef

Yeole BB, Kurkure AP. An epidemiological assessment of increasing incidence and trends in breast cancer in Mumbai and other sites in India, during the last two decades. Asian Pac J Cancer Prev. 2003;4:51–6.PubMed

Yip CH, Taib NA, Mohamed I. Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev. 2006;7:369–74.PubMed

Saxena S, Kaushal M, Sharma J, Zomawia E, Kapur S. Genomic alterations in breast cancer patients from Northeast India using 10 K SNP arrays. Genome Biol. 2010;11:34.CrossRef

Datta K, Biswas J. Influence of dietary habits, physical activity and affluence factors on breast cancer in East India—a case-control study. Asian Pac J Cancer Prev. 2009;10:219–22.PubMed

Cann RL, Stokening M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987;325:32–6.CrossRef

Anderson S, Bankier AT, Barrell BG, Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–65.CrossRefPubMed

10.

Czarnecka AM, Golik P, Bartnik E. Mitochondrial DNA mutations in human neoplasia. J Appl Genet. 2006;47:67–78.CrossRefPubMed

11.

Czarnecka AM, Marino Gammazza A, Di Felice V, Zummo G, Cappello F. Cancer as a ‘Mitochondriopathy’. J Cancer Mol. 2007;3:71–9.

12.

Czarnecka AM, Krawczyk T, Czarnecki JS, et al. Methodology for mitochondrial DNA research in oncology: goals and pitfalls. ARS Medica Tomitana. 2008;14:48–64.

13.

Carew JS, Huang P. Mitochondrial defects in cancer. Molecular Cancer. 2002;1:1–12.CrossRef

14.

Jonckheere ISJAM, Rodenburg RJT. Mitochondrial ATP synthase: architecture, function and pathology. J Inherit Metab Dis. 2012;35:221–5.CrossRef

15.

Ghatak S, Muthukumaran RB, Nachimuthu SK. A simple method of genomic DNA extraction from human samples for PCR-RFLP analysis. J Biomol Tech. 2013;24(4):224–31.PubMedPubMedCentral

16.

Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed

17.

Carroll KK, Braden LM. Dietary fat and mammary carcinogenesis. Nutr Cancer. 1985;6:254–9.CrossRef

18.

Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption. Cancer. 1986;58:2363–71.CrossRefPubMed

19.

Hirayama T. Epidemiology of breast cancer with special reference to the role of diet. Prev Med. 1978;7:173–95.CrossRefPubMed

20.

Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, Katsouyanni K, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst. 1990;82:561–9.CrossRefPubMed

21.

Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed

22.

Boyd NF, Martin LJ, Noffel M, Lockwood GA, Tritchler DL. A meta analysis of studies of dietary fat and breast cancer risk. Br J Cancer. 1993;68:627–36.CrossRefPubMedPubMedCentral

23.

Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, Folsom AR, et al. Cohort studies of fat intake and the risk of breast cancer—a pooled analysis. N Engl J Med. 1996;334:356–61.CrossRefPubMed

24.

Ghatak S, Doris L, Mawia L, Ricky S, Zothanpuia, Jeremy LP, Muthukumaran RB, Nachimuthu SK. Mitochondrial D-Loop and cytochrome oxidase subunit I polymorphisms among the breast cancer patients of Mizoram, Northeast India. Curr Genet. 2014;60:201–12.CrossRefPubMed

25.

Ghatak Lallawmzuali D, Mukherjee S, Mawia L, Pautu JL, Nachimuthu SK. Polymorphism in mtDNA control region of mizo-mongloid breast cancer samples as revealed by PCR-RFLP analysis. Mitochondrial DNA. 2014. doi:10.3109/19401736.2014.982627.PubMed

26.

Massoud G, Reza M, Forouzandeh F, Behnam K, Nasrin M, Massoud H. The mitochondrial ATPase6 gene is more susceptible to mutation than the ATPase8 gene in breast cancer patients. Cancer cell international. 2014;14:21.CrossRef

27.

Shidara YYK, Kanamori T, Nakano K, Kwong JQ, Manfredi G, Oda H, Ohta S. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res. 2005;65(5):1655–63.CrossRefPubMed

28.

Kirches E. Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics. 2009;10(4):281–92.CrossRefPubMedPubMedCentral

29.

Tan DJBR, Wong LJ. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972–6.PubMed

30.

Czarnecka AMKA, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E, Petros JA. Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep. 2010;23(2):531–5.PubMed

31.

Aikhionbare FOKM, Carey D, Okoli J, Go R. Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol Cancer. 2004;3:30.CrossRefPubMedPubMedCentral

32.

Aikhionbare FOMS, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, Partridge E. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007;6:1.CrossRefPubMedPubMedCentral

33.

Mehrabi SAJ, Adams G Jr, Grizzle W, Yao X, Aikhionbare FO. A sequence variant in colorectal adenomatous polyps. Diagn Pathol. 2010;5:66.CrossRefPubMedPubMedCentral

34.

Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989;123(3):585–95.PubMedPubMedCentral

Title: Mitochondrial complex I and V gene polymorphisms associated with breast cancer in mizo-mongloid population
Authors: Sunaina Thapa
Freda Lalrohlui
Souvik Ghatak
John Zohmingthanga
Doris Lallawmzuali
Jeremy L. Pautu
Nachimuthu Senthil Kumar
Publication date: 01-07-2016
Publisher: Springer Japan
Published in: Breast Cancer / Issue 4/2016
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.1007/s12282-015-0611-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2016

Diagnostic value of fine needle aspiration and core needle biopsy in special types of breast cancer

Analysis of prior mammography with negative result in women with interval breast cancer

Fulvestrant 500 mg in postmenopausal patients with metastatic breast cancer: the initial clinical experience

Characteristics of the Japanese histological classification for breast cancer: correlations with imaging and cytology

Pathological examination of breast cancer biomarkers: current status in Japan

Which patients require or can skip biopsy for breast clustered microcysts? Predictive findings of breast cancer and mucocele-like tumor

Keynote webinar | Spotlight on antibody–drug conjugates in cancer